Unichem Laboratories

599.05
-2.35
(-0.39%)
Market Cap
4,217.66 Cr
EPS
19.53
PE Ratio
30.97
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
937.95
52 Week Low
511.55
PB Ratio
1.73
Debt to Equity
0.14
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,672.50
#1 4,01,288.77
35.18
#1 54,729.00
12.06
#1 10,980
-18.99
48.33
6,938.00
1,84,182.10
83.40
9,360.00
0.89
2,117
23.05
68.54
1,488.30
1,20,211.16
23.71
28,409.50
7.12
5,291
30.28
54.26
3,322.40
1,12,445.11
59.20
11,539.40
11.59
1,911
10.91
62.08
1,283.80
1,07,142.24
#1 19.71
33,741.20
12.36
5,725
21.14
54.13
2,431.70
1,00,363.25
50.14
12,207.40
19.57
1,925
-10.91
59.65
983.20
98,932.93
21.52
22,573.80
13.82
3,977
-0.19
69.99
1,922.10
87,781.44
27.52
22,192.10
#1 19.94
3,024
#1 112.49
53.08
34,160.00
72,587.62
51.77
6,409.15
10.80
1,417
27.83
64.97
1,147.70
66,658.60
19.91
31,378.10
17.55
3,366
-0.50
63.70
Forecast
Actual
Growth Rate
Revenue Growth
25.70 %
Net Income Growth
-65.13 %
Cash Flow Change
-150.14 %
ROE
-64.10 %
ROCE
-74.64 %
EBITDA Margin (Avg.)
-1,588.24 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,275
3,569
Fixed Assets
416
403
491
578
810
870
884
990
1,257
1,252
1,300
Current Assets
564
600
749
2,337
2,038
1,687
1,377
1,648
1,589
1,743
2,030
Capital Work in Progress
123
237
250
238
92
331
568
494
148
123
31
Investments
35
14
14
901
926
550
392
264
2
1
0
Other Assets
595
630
772
1,476
1,321
1,395
1,282
1,571
1,787
1,899
2,239
Total Liabilities
1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,275
3,569
Current Liabilities
212
243
393
464
503
567
506
552
640
738
992
Non Current Liabilities
89
86
70
50
27
47
63
148
118
99
127
Total Equity
868
954
1,064
2,680
2,620
2,531
2,557
2,618
2,435
2,438
2,451
Reserve & Surplus
849
936
1,045
2,666
2,606
2,517
2,543
2,604
2,421
2,424
2,437
Share Capital
18
18
18
14
14
14
14
14
14
14
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-25
-7
-1
655
-616
-78
-154
32
75
-29
-65
Investing Activities
-52
-85
-128
1,648
-286
-36
-66
100
241
63
-242
Operating Activities
78
112
68
-112
-328
20
33
-260
-85
14
-7
Financing Activities
-51
-33
59
-881
-2
-62
-121
191
-81
-106
184

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
70.21 %
70.22 %
70.22 %
70.22 %
70.22 %
70.22 %
70.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.83 %
0.00 %
0.90 %
0.89 %
0.94 %
1.06 %
0.98 %
DIIs
8.49 %
8.49 %
8.49 %
8.49 %
8.49 %
8.38 %
7.55 %
8.20 %
8.16 %
7.39 %
10.32 %
9.29 %
11.27 %
11.58 %
11.67 %
11.63 %
11.32 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.48 %
30.39 %
30.50 %
30.27 %
29.81 %
29.95 %
30.17 %
30.99 %
30.91 %
26.86 %
15.80 %
15.63 %
15.12 %
14.80 %
14.58 %
14.47 %
14.80 %
Others
10.09 %
10.19 %
10.08 %
10.31 %
10.77 %
10.73 %
11.34 %
9.87 %
9.99 %
14.81 %
2.84 %
4.85 %
2.49 %
2.50 %
2.60 %
2.62 %
2.67 %
No of Share Holders
0
33,734
34,258
33,892
35,313
33,557
32,666
29,573
29,418
26,642
21,584
20,877
21,171
20,621
20,374
21,472
21,621

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 3 5 4 4 4 4 4 0.00 0.00
Dividend Yield (%) 0.00 1.05 2.57 2.57 1.29 1.54 1.39 0.81 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
04 Aug 2025 586.60 601.40
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2025 552.20 625.45
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 686.45 733.15
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 765.60 876.05
08 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Aug 2024 531.95 578.30
03 Aug 2022 DIVIDEND Dividend
₹ 4.00 /share
01 Aug 2022 235.75 292.05
26 Jul 2021 DIVIDEND Dividend
₹ 4.00 /share
22 Jul 2021 360.90 334.50

Announcements

Announcement Under Regulation 30 (LODR) Regulation 2015 - Update3 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Notice Of 62Nd Annual General Meeting4 days ago
Business Responsibility and Sustainability Reporting (BRSR)4 days ago
Reg. 34 (1) Annual Report.4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Closure of Trading WindowJun 26, 2025
USFDA Audit Of Our Roha API FacilityJun 21, 2025
Annual General Meeting On 4Th August 2025Jun 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Results For Quarter And Year Ended 2025May 22, 2025
Board Meeting Outcome for OutcomeMay 22, 2025
USFDA Inspection Report For Pithampur API PlantMay 14, 2025
Board Meeting Intimation for Consider And Approve Financial Results For Quarter And Year Ended March 31 2025May 08, 2025
Intimation Of Change In Contact Details Of Registrar And Share Transfer Agent (RTA)Apr 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingMar 28, 2025
Closure of Trading WindowMar 25, 2025
Announcement Under Regulation 30Mar 20, 2025
USFDA Approval For CompanyS Pithampur API FacilityMar 01, 2025
Board Meeting Outcome for Outcome Of Board MeetingMar 01, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025
Integrated Filing (Financial)Feb 06, 2025
Financial ResultsFeb 06, 2025
Included Mr. Utkarsh Patil Chief Manufacturing Officer - Formulations As A Senior Management Personnel Under SEBI LODR Regulations With Effect From 6Th February 2025Feb 06, 2025
Board Meeting Outcome for Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine-Months Ended 31St December 2024Feb 06, 2025
Announcement Under Regulation 30(LODR) - GST (Goods &Services Tax)Jan 27, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 24, 2025
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.Jan 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Intimation By Registrar & Transfer Agent (RTA)Jan 03, 2025
Resignation Of Senior Managerial Personnel.Dec 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationNov 13, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 13, 2024
Board Meeting Outcome for Unaudited Financial Statements (Consolidated & Standalone) For The Second Quarter And Half Year Ended 30Th September 2024Nov 13, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 10, 2024
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2024.Oct 25, 2024
Reply Letter On A Significant Increase In The Volume.Oct 23, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 11, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 04, 2024
Board Meeting Outcome for Outcome Of Board MeetingSep 30, 2024
Closure of Trading WindowSep 23, 2024
Board Meeting Intimation for Integration And Consolidation Of The Generics FormulationsBusiness In The US Market.Sep 23, 2024
Intimation Under Regulation 30 Of SEBI LODRSep 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressSep 03, 2024

Technical Indicators

RSI(14)
Neutral
52.30
ATR(14)
Volatile
19.96
STOCH(9,6)
Neutral
55.36
STOCH RSI(14)
Neutral
79.98
MACD(12,26)
Bullish
0.87
ADX(14)
Weak Trend
9.14
UO(9)
Bearish
37.81
ROC(12)
Uptrend And Accelerating
5.48
WillR(14)
Neutral
-22.86

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Small Cap Fund Direct- Growth
0.00%
-5473134
-0.96%
-1.07%
DSP Healthcare Fund Direct - Growth
0.00%
-852063
-1.72%
-1.76%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-241030
-0.26%
-0.27%
Quant Value Fund Direct - Growth
0.00%
-61132
-0.20%
-0.21%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
-291
-0.10%
-0.10%
Franklin India Opportunities Direct Fund-Growth
0.00%
0
0.00%
-0.15%
HDFC Pharma And Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%